Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IntrinsiQ Research is a leading provider of oncology-focused data analytics and software solutions, primarily serving the pharmaceutical industry and community oncology practices. The company specializes in capturing and analyzing real-world evidence (RWE) from clinical workflows to provide insights into treatment patterns, drug utilization, and patient outcomes. Its core offerings include the IntelliDose clinical information system and comprehensive longitudinal databases that track chemotherapy administration. Now a part of Cencora (formerly AmerisourceBergen), IntrinsiQ helps stakeholders optimize clinical decision-making and commercial strategies within the oncology landscape. The company's data is widely used for market research, health economics and outcomes research (HEOR), and competitive intelligence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IntrinsiQ Research.